261 related articles for article (PubMed ID: 22769244)
21. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
[TBL] [Abstract][Full Text] [Related]
22. Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways.
Chen NG; Lu CC; Lin YH; Shen WC; Lai CH; Ho YJ; Chung JG; Lin TH; Lin YC; Yang JS
Oncol Rep; 2011 Oct; 26(4):939-47. PubMed ID: 21743966
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Fatty Acid Synthase Sensitizes Prostate Cancer Cells to Radiotherapy.
Rae C; Haberkorn U; Babich JW; Mairs RJ
Radiat Res; 2015 Nov; 184(5):482-93. PubMed ID: 26484401
[TBL] [Abstract][Full Text] [Related]
24. C75 alters central and peripheral gene expression to reduce food intake and increase energy expenditure.
Tu Y; Thupari JN; Kim EK; Pinn ML; Moran TH; Ronnett GV; Kuhajda FP
Endocrinology; 2005 Jan; 146(1):486-93. PubMed ID: 15498887
[TBL] [Abstract][Full Text] [Related]
25. Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer.
Ali A; Levantini E; Teo JT; Goggi J; Clohessy JG; Wu CS; Chen L; Yang H; Krishnan I; Kocher O; Zhang J; Soo RA; Bhakoo K; Chin TM; Tenen DG
EMBO Mol Med; 2018 Mar; 10(3):. PubMed ID: 29449326
[TBL] [Abstract][Full Text] [Related]
26. The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells.
Milligan SA; Burke P; Coleman DT; Bigelow RL; Steffan JJ; Carroll JL; Williams BJ; Cardelli JA
Clin Cancer Res; 2009 Aug; 15(15):4885-94. PubMed ID: 19638461
[TBL] [Abstract][Full Text] [Related]
27. The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
Zhou H; Fu LX; Li L; Chen YY; Zhu HQ; Zhou JL; Lv MX; Gan RZ; Zhang XX; Liang G
J Ethnopharmacol; 2020 Oct; 261():113118. PubMed ID: 32621953
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antitumor activity of an inhibitor of fatty acid synthase.
Kuhajda FP; Pizer ES; Li JN; Mani NS; Frehywot GL; Townsend CA
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3450-4. PubMed ID: 10716717
[TBL] [Abstract][Full Text] [Related]
29. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
[TBL] [Abstract][Full Text] [Related]
30. Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis.
Goswami S; Sharma-Walia N
Oncotarget; 2016 Sep; 7(37):58953-58974. PubMed ID: 27270654
[TBL] [Abstract][Full Text] [Related]
31. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells.
Wang HQ; Altomare DA; Skele KL; Poulikakos PI; Kuhajda FP; Di Cristofano A; Testa JR
Oncogene; 2005 May; 24(22):3574-82. PubMed ID: 15806173
[TBL] [Abstract][Full Text] [Related]
32. Differential in radiosensitizing potency of enantiomers of the fatty acid synthase inhibitor C75.
Rae C; Babich JW; Mairs RJ
Chirality; 2017 Jan; 29(1):10-13. PubMed ID: 27901292
[TBL] [Abstract][Full Text] [Related]
33. Epigallocatechin-3-gallate inhibits proliferation and triggers apoptosis in colon cancer via the hedgehog/phosphoinositide 3-kinase pathways.
Ding F; Yang S
Can J Physiol Pharmacol; 2021 Sep; 99(9):910-920. PubMed ID: 33617370
[TBL] [Abstract][Full Text] [Related]
34. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
Yamauchi R; Sasaki K; Yoshida K
Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
[TBL] [Abstract][Full Text] [Related]
35. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
36. Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs.
Blancafort A; Giró-Perafita A; Oliveras G; Palomeras S; Turrado C; Campuzano Ò; Carrión-Salip D; Massaguer A; Brugada R; Palafox M; Gómez-Miragaya J; González-Suárez E; Puig T
PLoS One; 2015; 10(6):e0131241. PubMed ID: 26107737
[TBL] [Abstract][Full Text] [Related]
37. Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase.
Wang X; Tian W
Biochem Biophys Res Commun; 2001 Nov; 288(5):1200-6. PubMed ID: 11700039
[TBL] [Abstract][Full Text] [Related]
38. Effects of anti-proliferative lichen metabolite, protolichesterinic acid on fatty acid synthase, cell signalling and drug response in breast cancer cells.
Bessadóttir M; Skúladóttir EÁ; Gowan S; Eccles S; Ögmundsdóttir S; Ogmundsdóttir HM
Phytomedicine; 2014 Oct; 21(12):1717-24. PubMed ID: 25442282
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of fatty acid synthase with C75 decreases organ injury after hemorrhagic shock.
Kuncewitch M; Yang WL; Jacob A; Khader A; Giangola M; Nicastro J; Coppa GF; Wang P
Surgery; 2016 Feb; 159(2):570-9. PubMed ID: 26372196
[TBL] [Abstract][Full Text] [Related]
40. The anorexigenic fatty acid synthase inhibitor, C75, is a nonspecific neuronal activator.
Takahashi KA; Smart JL; Liu H; Cone RD
Endocrinology; 2004 Jan; 145(1):184-93. PubMed ID: 14512433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
